December 05, 2011
Press Release No. 1
News about Tilaknagar Industries Limited
The media had reports that Tilaknagar Industries
Limited may form a joint venture with a European liquor company.
The Exchange, in order to verify the accuracy or
otherwise of the information reported in the media and to inform the market
place so that the interest of the investors is safeguarded, had written to the
company.
Tilaknagar Industries Limited has vide its letter
inter-alia stated, "As a part of its planned expansion in the branded
spirit market, the Company has had preliminary round of meeting with an
international liquor major to explore the possibility of forming a separate
joint venture. Since, the discussions are at preliminary stage, therefore, the
identity of the said international company can't be disclosed at this stage and
will be disclosed at the time of finalization of the transaction."
Press Release No. 2
Clarification by Apollo Hospitals
Enterprise Limited
Substantial increases in trading volumes have been
observed in Apollo Hospitals Enterprise Limited.
The Exchange, in order to ensure that investors have
latest relevant information about the company and to inform the market place so
that the interest of the investors is safeguarded, had written to the company.
Apollo Hospitals Enterprise Limited has vide its
letter inter-alia stated, “There is no information/announcement (including
pending announcements) which could have a bearing on the price/ volume behavior
in our scrip."
Press Release No. 3
Market-wide Position Limit in ABGSHIP
The
derivative contracts in the underlying ABGSHIP have crossed 95% of the
market-wide position limit on December 05, 2011. It is hereby informed that all
clients/ members shall trade in derivative contracts of ABGSHIP by offsetting
their existing positions till the open interest comes down to 80% of the market wide position limit.
Press Release No. 4
Security listed and admitted to dealings –
POLYMED, SHARONBIO & RUPA
The equity shares of the
following companies shall be listed and admitted to dealings on the
Exchange w.e.f. December 07, 2011. Trading shall be in the Normal Market segment – Compulsory
Demat (Rolling Settlement) for all investors.
|
Sr. No. |
Symbol |
Name of the Company |
ISIN Code |
|
1 |
POLYMED |
Poly
Medicure Limited |
INE205C01013 |
|
2 |
SHARONBIO |
Sharon Bio-Medicine Limited |
INE028B01011 |
|
3 |
RUPA |
Rupa & Company Limited |
INE895B01021 |
Press Release No. 5
NSE completes its 2941st
Normal Settlement
The Exchange has
successfully completed its 2941st Normal
Settlement (Rolling T+2 following SEBI directive) since inception i.e.,
Settlement Number N – 2011227 on Dec 05, 2011. The settlement statistics are as
follows:
|
Particulars |
|
|
|
N-2011227 |
|
Total traded quantity (lakhs) |
5712.15 |
|
Total traded value (Rs. In Crores) |
10310.77 |
|
Total value of the settlement (Securities) (Rs. In Crores) |
2897.75 |
|
Total value of the settlement (Funds) (Rs. In Crores) |
1116.38 |
|
Shortages for the settlement |
0.07% |
|
% of Delivery ( No. of shares
deliverable / No. of shares traded ) |
30.14% |
Retail Debt
Market has completed its 2214th settlement, details of which are as
follows:
|
Settlement
No. |
Traded
Value |
Settlement
Value |
|
|
|
|
Securities |
Funds |
|
D- 2011227 |
NIL |
NIL |
NIL |